News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
295,154 Results
Type
Article (28214)
Company Profile (67)
Press Release (266873)
Section
Business (77401)
Career Advice (873)
Deals (11048)
Drug Delivery (44)
Drug Development (46179)
Employer Resources (78)
FDA (6863)
Job Trends (6940)
News (141875)
Policy (14304)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (2)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (5)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (2)
2024 Genetown Digital (1)
2024 Genetown Standard (3)
2024 Pharm Country Standard (2)
2026 Genetown Elite (1)
Academia (2189)
Accelerated approval (2)
Adcomms (14)
Allergies (32)
Alliances (24262)
ALS (39)
Alzheimer's disease (824)
Antibody-drug conjugate (ADC) (47)
Approvals (6886)
Artificial intelligence (146)
Autoimmune disease (8)
Automation (8)
Bankruptcy (82)
Best Places to Work (6096)
BIOSECURE Act (16)
Biosimilars (34)
Biotechnology (51)
Bladder cancer (29)
Brain cancer (14)
Breast cancer (147)
Cancer (1119)
Cardiovascular disease (58)
Career advice (723)
Career pathing (10)
CAR-T (73)
Cell therapy (203)
Cervical cancer (16)
Clinical research (35457)
Collaboration (440)
Compensation (54)
Complete response letters (5)
COVID-19 (2491)
CRISPR (32)
C-suite (107)
Cystic fibrosis (61)
Data (1179)
Denatured (4)
Depression (10)
Diabetes (99)
Diagnostics (2710)
Digital health (6)
Diversity (3)
Diversity, equity & inclusion (20)
Drug discovery (61)
Drug pricing (44)
Drug shortages (6)
Duchenne muscular dystrophy (34)
Earnings (23070)
Editorial (15)
Employer branding (9)
Employer resources (69)
Events (39326)
Executive appointments (279)
FDA (7449)
Featured Employer (17)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (403)
Gene editing (71)
Generative AI (15)
Gene therapy (168)
GLP-1 (292)
Government (3039)
Grass and pollen (2)
Guidances (21)
Healthcare (8722)
Huntington's disease (8)
IgA nephropathy (8)
Immunology and inflammation (48)
Indications (14)
Infectious disease (2620)
Inflammatory bowel disease (86)
Inflation Reduction Act (5)
Influenza (50)
Intellectual property (35)
Interviews (116)
IPO (5301)
IRA (23)
Job creations (1157)
Job search strategy (642)
Kidney cancer (5)
Labor market (11)
Layoffs (165)
Leadership (6)
Legal (2165)
Liver cancer (29)
Lung cancer (162)
Lymphoma (62)
Machine learning (3)
Management (29)
Manufacturing (114)
MASH (18)
Medical device (4188)
Medtech (4188)
Mergers & acquisitions (5971)
Metabolic disorders (237)
Multiple sclerosis (48)
NASH (8)
Neurodegenerative disease (38)
Neuropsychiatric disorders (6)
Neuroscience (1058)
NextGen: Class of 2025 (2699)
Non-profit (2589)
Northern California (1039)
Now hiring (9)
Obesity (115)
Opinion (107)
Ovarian cancer (47)
Pain (34)
Pancreatic cancer (36)
Parkinson's disease (67)
Partnered (9)
Patents (78)
Patient recruitment (54)
Peanut (20)
People (25512)
Pharmaceutical (18)
Pharmacy benefit managers (5)
Phase I (13306)
Phase II (15226)
Phase III (10509)
Pipeline (555)
Podcasts (20)
Policy (79)
Postmarket research (1314)
Preclinical (6084)
Press Release (42)
Prostate cancer (45)
Psychedelics (22)
Radiopharmaceuticals (106)
Rare diseases (196)
Real estate (2142)
Recruiting (32)
Regulatory (10244)
Reports (18)
Research institute (2147)
Resumes & cover letters (165)
Rett syndrome (2)
RNA editing (3)
RSV (47)
Schizophrenia (20)
Series A (69)
Series B (39)
Service/supplier (1)
Sickle cell disease (40)
Southern California (896)
Special edition (1)
Spinal muscular atrophy (77)
Sponsored (14)
Startups (1853)
Stomach cancer (5)
Supply chain (27)
Tariffs (5)
The Weekly (15)
United States (9644)
Vaccines (772)
Venture capitalists (15)
Webinars (8)
Weight loss (57)
Women's health (10)
Worklife (5)
Date
Last 7 days (307)
Last 30 days (1179)
Last 365 days (15532)
2025 (3679)
2024 (16543)
2023 (19033)
2022 (25506)
2021 (27477)
2020 (24790)
2019 (19907)
2018 (15153)
2017 (14214)
2016 (13874)
2015 (16237)
2014 (12125)
2013 (10161)
2012 (10566)
2011 (11082)
2010 (9716)
Location
Africa (442)
Alabama (33)
Alaska (5)
Arizona (74)
Arkansas (6)
Asia (19179)
Australia (3843)
California (2336)
Canada (779)
China (222)
Colorado (93)
Connecticut (115)
Delaware (69)
Europe (41664)
Florida (413)
Georgia (84)
Hawaii (1)
Idaho (19)
Illinois (200)
India (14)
Indiana (116)
Iowa (1)
Japan (74)
Kansas (31)
Kentucky (15)
Louisiana (5)
Maine (11)
Maryland (532)
Massachusetts (1849)
Michigan (70)
Minnesota (121)
Missouri (35)
Montana (15)
Nebraska (12)
Nevada (11)
New Hampshire (19)
New Jersey (900)
New Mexico (12)
New York (788)
North Carolina (406)
North Dakota (7)
Northern California (1039)
Ohio (84)
Oklahoma (9)
Oregon (11)
Pennsylvania (555)
Puerto Rico (3)
Rhode Island (14)
South America (486)
South Carolina (7)
Southern California (896)
Tennessee (33)
Texas (381)
Utah (60)
Virginia (56)
Washington D.C. (38)
Washington State (285)
West Virginia (2)
Wisconsin (16)
295,154 Results for "duke human vaccine institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Vaccines
FDA Issues Back-to-Back Vaccine Approvals as RFK Jr. Takes HHS Seat
The approvals come as Robert F. Kennedy Jr.—who has been critical of vaccines—takes leadership of the Department of Health and Human Services.
February 17, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Thermo Fisher Scientific and Chan Zuckerberg Institute for Advanced Biological Imaging Collaborate to Further Understanding of Human Cells
March 28, 2025
·
4 min read
Vaccines
CDC Vaccine Advisory Board Meeting Postponed Days After RFK Jr. Confirmation
The postponed ACIP meeting comes barely a week after Robert F. Kennedy, Jr. was confirmed as Secretary of Health and Human Services, despite controversy regarding his anti-vaccine history.
February 21, 2025
·
2 min read
·
Tristan Manalac
Drug Development
Saghmos Therapeutics Announces Collaboration with Duke Clinical Research Institute to Optimize Phase 3 Cardio-Renal Metabolic Study
Saghmos Therapeutics, Inc. (Saghmos), a privately held biopharmaceutical company, announced it will partner with the Duke Clinical Research Institute (DCRI) to optimize all aspects of and plan the operationalization of Saghmos’ Phase 3 study for its cardio-renal metabolic modulator ST-62516.
April 17, 2024
·
4 min read
Press Releases
Replicate Bioscience Announces Publication of First-in-Human Data for Its Optimized srRNA Rabies Vaccine in Nature Communications
February 7, 2025
·
5 min read
Vaccines
Moderna Nabs Another $590M from HHS for mRNA-Based Bird Flu Vaccines
The funding, which follows the $176 million the government awarded Moderna in June 2024, aims to get mRNA vaccines ready before bird flu strains currently circulating in the wild and on farms can potentially cause human outbreaks.
January 21, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Daxor Corporation Announces New Data from Duke University and Highlights Key BVA Insights at American College of Cardiology’s 74th Annual Scientific Session and Expo
April 2, 2025
·
4 min read
Policy
RFK Jr. to Cut 10,000 Jobs Across HHS
The announcement by the Department of Health and Human Services highlighted a flurry of moves, which include the shifting of departments. Also this week, HHS Secretary Robert F. Kennedy Jr. tapped fellow vaccine critic David Geier to investigate vaccine safety within the CDC.
March 27, 2025
·
2 min read
·
Tristan Manalac
BioCapital
Longhorn Vaccines and Diagnostics Presents at World Vaccine Congress on Advantages of Single Peptide Vaccine for Broad Coverage of Human and Avian Influenza Viruses
Longhorn Vaccines and Diagnostics Congress all day April 2-4, 2024 on a mice study that examined LHNVD-110, a novel, unconjugated single peptide vaccine comprised of multiple epitopes to broadly target human and influenza viruses.
April 2, 2024
·
4 min read
Vaccines
Doctors Rally Behind Vaccines as Doubts, Misinformation Mount
A group of medical experts expressed concern about growing “disinformation” and “misinformation,” calling for adherence to recommended vaccine schedules.
March 20, 2025
·
2 min read
·
Tristan Manalac
1 of 29,516
Next
